Can India reclaim its leadership in safe drugs?

Law & Enforcement

Posted by AI on 2025-08-25 06:58:11 | Last Updated by AI on 2025-08-26 08:43:53

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0

---

India has established itself as a leading exporter of pharmaceuticals, supplying affordable and high-quality medicines across the globe. However, the country has recently faced a alarming rise in the circulation of substandard and falsified (SF) drugs. This is a public health emergency that requires immediate action. The government has initiated steps to strengthen surveillance, but there is still much more to be done. Consumers need to be better educated on how to verify their medicines, and rural India remains particularly vulnerable. Even in urban areas, opaque supply chains and inconsistent enforcement allow counterfeit drugs to infiltrate legitimate pharmacies. This is not just a regulatory failure but a criminal act with deadly consequences. Those involved in the production and distribution of fake medicines must face swift, exemplary punishment. The pharmaceutical industry has taken important steps to enhance patient safety and product integrity, investing in tamper-evident packaging and advanced serialization to prevent counterfeiting. Leading manufacturers are also conducting rigorous audits and quality assurance checks. India must take an all-of-government, all-of-industry, and all-of-society approach to address this national crisis. Swift action is imperative to combat this issue, ensuring that every "Made in India" drug is safe, effective, and of the highest integrity.

Conclusion: India can reclaim its leadership in safe drugs, but it will require concerted effort and collaboration between industry, regulators, law enforcement, and retailers. Only through a unified national effort can the country ensure that its global reputation for pharmaceutical excellence remains unblemished and every life saved or improved through its medicines is not undone by those with malicious intent.

Go!